Cargando…

The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART

INTRODUCTION: The source and significance of residual plasma HIV-1 RNA detection during suppressive ART remain controversial. It has been proposed that nevirapine (NVP)-based regimens achieve a greater HIV-1 RNA suppression than regimens containing a protease inhibitor (PI). The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiselinova, Maja, Anna, Maria, Malatinkova, Eva, Vervish, Karen, Beloukas, Apostolos, Messiaen, Peter, Bonczkowski, Pawel, Trypsteen, Wim, Callens, Steven, Verhofstede, Chris, De Spiegelaere, Ward, Vandekerckhove, Linos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P291
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225357/ https://www.ncbi.nlm.nih.gov/pubmed/25397567 http://dx.doi.org/10.7448/IAS.17.4.19823

Ejemplares similares

Accurate episomal HIV 2-LTR circles quantification using optimized DNA isolation and droplet digital PCR
por: Malatinkova, Eva, et al.
Publicado: (2014)

Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs
por: Malatinkova, Eva, et al.
Publicado: (2015)

CARE Score on Chest Radiograph at Diagnosis Predicts Early and Late Outcomes Among Lung Transplant Patients with COVID-19
por: Halverson, Q.M., et al.
Publicado: (2022)

Oxygénothérapie à haut débit (OHD) chez les patients atteints du COVID-19
por: Mokni, A., et al.
Publicado: (2022)

Diagnostic utility of droplet digital PCR for HIV reservoir quantification
por: Trypsteen, Wim, et al.
Publicado: (2016)

Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care
por: De Spiegelaere, Ward, et al.
Publicado: (2015)

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth
por: Kiselinova, Maja, et al.
Publicado: (2016)

Correction: Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth
por: Kiselinova, Maja, et al.
Publicado: (2016)

Replication competent virus as an important source of bias in HIV latency models utilizing single round viral constructs
por: Bonczkowski, Pawel, et al.
Publicado: (2014)

SURTO DE COLONIZAÇÃO/INFECÇÃO POR PSEUDOMONAS AERUGINOSA EM UTI DE PACIENTES COM COVID‐19: DESCRIÇÃO DE CASOS E MEDIDAS ADOTADAS
por: Silva, Lais M., et al.
Publicado: (2021)

The use of HIV-1 integration site analysis information in clinical studies aiming at HIV cure
por: Kiselinova, Maja, et al.
Publicado: (2016)

Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models
por: Bonczkowski, Pawel, et al.
Publicado: (2016)

In-depth validation of total HIV-1 DNA assays for quantification of various HIV-1 subtypes
por: Rutsaert, Sofie, et al.
Publicado: (2018)

Switching to nevirapine-based regimens after undetectable viral load is not associated with increased risk of discontinuation due to toxicity
por: Patterson, Patricia, et al.
Publicado: (2014)

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ
por: Ruggiero, Alessandra, et al.
Publicado: (2015)

HIV Reservoir Characterization Symposium: 19 September 2016, Ghent, Belgium
por: Malatinkova, Eva, et al.
Publicado: (2017)

Comparison of Droplet Digital PCR and Seminested Real-Time PCR for Quantification of Cell-Associated HIV-1 RNA
por: Kiselinova, Maja, et al.
Publicado: (2014)

Underestimated effect of intragenic HIV-1 DNA methylation on viral transcription in infected individuals
por: Kint, Sam, et al.
Publicado: (2020)

Sex differences in apolipoprotein A1 and nevirapine-induced toxicity
por: Marinho, Aline, et al.
Publicado: (2014)

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
por: Crouzat, Frederic, et al.
Publicado: (2014)

Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors
por: Van Hecke, Clarissa, et al.
Publicado: (2019)

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
por: Saracino, Annalisa, et al.
Publicado: (2014)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: 96 weeks post VERITAS study
por: Trottier, Benoit, et al.
Publicado: (2014)

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Factors associated with the continuum of care of HIV-infected patients in Belgium
por: Van Beckhoven, Dominique, et al.
Publicado: (2014)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014)

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Alu Repeat Sequences
por: Malatinkova, Eva, et al.
Publicado: (2021)

Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
por: Marije Hofstra, Laura, et al.
Publicado: (2014)

Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
por: Gutierrez-Liarte, Angela, et al.
Publicado: (2014)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Clinical and socio-demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART-1
por: Daniel Labhardt, Niklaus, et al.
Publicado: (2014)

A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expect
por: Silva, Joana, et al.
Publicado: (2014)

Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study
por: Leierer, Gisela, et al.
Publicado: (2014)

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
por: Fisher, Martin, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_29q7qib0qvre4r3p3aadmnc9bq